Biological Products, (No Diagnostic Substances) · DE · CIK 1650648
Advancing durable, disease-targeted gene therapies for ophthalmology, cardiology, and pulmonology
Comparable business profile · signals at a glance
In the 90 days to Mar 20, 2026: 1 sold $7K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 20, 2026 | Gupta AshooVP, Finance and Controller | Sell | 310 | $8.61 | $3K |
| Mar 20, 2026 | Gupta AshooVP, Finance and Controller | Sell | 80 | $8.61 | $689 |
| Dec 20, 2025 | Gupta AshooVP, Finance and Controller | Sell | 310 | $8.68 | $3K |
| Dec 20, 2025 | Gupta AshooVP, Finance and Controller | Sell | 79 | $8.68 | $686 |
| Dec 16, 2025 | Bizily ScottChief Legal Officer | Sell | 1,635 | $10.90 | $18K |
| Nov 17, 2025 | Bizily ScottChief Legal Officer | Sell | 1,635 | $10.59 | $17K |
| Oct 24, 2025 | Bizily ScottChief Legal Officer | Sell | 2,678 | $12.00 | $32K |
| Oct 16, 2025 | Bizily ScottChief Legal Officer | Sell | 1,635 | $10.17 | $17K |
| Oct 9, 2025 | Bizily ScottChief Legal Officer | Sell | 2,408 | $10.00 | $24K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.